Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study.

Castanedo-Cazares, Juan Pablo; Lárraga-Piñones, Gabryela; Ehnis-Pérez, Adriana; Fuentes-Ahumada, Cornelia; Oros-Ovalle, Cuauhtemoc; Smoller, Bruce R; Torres-Álvarez, Bertha.

Affiliation

Clin Cosmet Investig Dermatol ; 6: 29-36, 2013.

Article in En | MEDLINE | ID: mdl-23355788

Key words

desonide; niacinamide; post-inflammatory hyperpigmentation

Full text: 1 Database: MEDLINE Type of study: Clinical_trials Language: En Year: 2013 Type: Article

Full text: 1 Database: MEDLINE Type of study: Clinical_trials Language: En Year: 2013 Type: Article